Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Comprehensive Cancer Care Improvement Act of 2007
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: POWELL GOLDSTEIN LLP
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments [Comprehensive Cancer Care Improvement Act (H.R. 1078) -- all provisions; Legislation pertaining to Medicare average sales price for pharmaceuticals (H.R. 3011) -- all provisions; Medicare Improvements for Patients and Providers Act (H.R. 6331) -- support provisions pertaining to physician payments]
Comprehensive Cancer Care Improvement Act of 2007
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: POWELL GOLDSTEIN LLP
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
THERAGENICS CORPORATION via POWELL GOLDSTEIN LLP
2008 · fourth_quarter · 4T
Issues regarding Medicare reimbursement and coverage for cancer therapies
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via POWELL GOLDSTEIN LLP
2008 · fourth_quarter · 4T
Source: Senate LDA
| ASSN OF COMMUNITY CANCER |
| 4 |
| 2000–2002 |
| CONSOLIDATED BILLING COALITION | 3 | 2000 |
| HYOX MEDICAL TREATMENT CENTER INC | 3 | 2005 |
| RESPIRONICS | 3 | 1999–2000 |
| U S ONCOLOGY | 2 | 1999 |
| CITY OF DEKALB | 1 | 2000 |
| CITY OF FREEPORT | 1 | 2000 |
| INTL ANTICOUNTERFEITING COALITION (IACC) | 1 | 2000 |
| NAMM INTL MUSIC PRODUCTS ASSN | 1 | 2003 |
| NETRX | 1 | 2003 |
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments (Comprehensive Cancer Care Improvement Act (H.R. 1078) -- all provisions; Legislation pertaining to Medicare average sales price (H.R. 3011) -- all provisions)
Comprehensive Cancer Care Improvement Act of 2007
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: POWELL GOLDSTEIN LLP
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments [Comprehensive Cancer Care Improvement Act (H.R. 1078) -- all provisions; Legislation pertaining to Medicare average sales price for pharmaceuticals (H.R. 3011) -- all provisions; Medicare Improvements for Patients and Providers Act (H.R. 6331) -- support provisions pertaining to physician payments]
Comprehensive Cancer Care Improvement Act of 2007
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: POWELL GOLDSTEIN LLP
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments [Comprehensive Cancer Care Improvement Act (H.R. 1078) -- all provisions; Legislation pertaining to Medicare average sales price for pharmaceuticals (H.R. 3011) -- all provisions]
To amend title XVIII of the Social Security Act to ensure adequate payment amounts for drugs and biologicals under part B of the Medicare Program.
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: POWELL GOLDSTEIN LLP
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments [Comprehensive Cancer Care Improvement Act (H.R. 1078) -- all provisions; Legislation pertaining to Medicare average sales price for pharmaceuticals (H.R. 3011) -- all provisions; Medicare Improvements for Patients and Providers Act (H.R. 6331) -- support provisions pertaining to physician payments]
To amend title XVIII of the Social Security Act to ensure adequate payment amounts for drugs and biologicals under part B of the Medicare Program.
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: POWELL GOLDSTEIN LLP
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments [Comprehensive Cancer Care Improvement Act (H.R. 1078) -- all provisions; Legislation pertaining to Medicare average sales price for pharmaceuticals (H.R. 3011) -- all provisions; Medicare Improvements for Patients and Providers Act (H.R. 6331) -- support provisions pertaining to physician payments]
To amend title XVIII of the Social Security Act to ensure adequate payment amounts for drugs and biologicals under part B of the Medicare Program.
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: POWELL GOLDSTEIN LLP
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments (Comprehensive Cancer Care Improvement Act (H.R. 1078) -- all provisions; Legislation pertaining to Medicare average sales price (H.R. 3011) -- all provisions)
To amend title XVIII of the Social Security Act to ensure adequate payment amounts for drugs and biologicals under part B of the Medicare Program.
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: POWELL GOLDSTEIN LLP
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments [Comprehensive Cancer Care Improvement Act (H.R. 1078) -- all provisions; Legislation pertaining to Medicare average sales price for pharmaceuticals (H.R. 3011) -- all provisions]
Medicare Improvements for Patients and Providers Act of 2008
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: POWELL GOLDSTEIN LLP
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments [Comprehensive Cancer Care Improvement Act (H.R. 1078) -- all provisions; Legislation pertaining to Medicare average sales price for pharmaceuticals (H.R. 3011) -- all provisions; Medicare Improvements for Patients and Providers Act (H.R. 6331) -- support provisions pertaining to physician payments]
Medicare Improvements for Patients and Providers Act of 2008
Client: THERAGENICS CORPORATION · Firm: POWELL GOLDSTEIN LLP
Issues regarding Medicare reimbursement and coverage for cancer therapies [Medicare Improvements for Patients and Providers Act (H.R. 6331) -- provision pertaining to brachytherapy]
Medicare Improvements for Patients and Providers Act of 2008
Client: THERAGENICS CORPORATION · Firm: POWELL GOLDSTEIN LLP
Issues regarding Medicare reimbursement and coverage for cancer therapies [Medicare Improvements for Patients and Providers Act (H.R. 6331) -- provision pertaining to brachytherapy]
Medicare Improvements for Patients and Providers Act of 2008
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: POWELL GOLDSTEIN LLP
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments [Comprehensive Cancer Care Improvement Act (H.R. 1078) -- all provisions; Legislation pertaining to Medicare average sales price for pharmaceuticals (H.R. 3011) -- all provisions; Medicare Improvements for Patients and Providers Act (H.R. 6331) -- support provisions pertaining to physician payments]
Comprehensive Cancer Care Improvement Act of 2007
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: POWELL GOLDSTEIN LLP
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments (H.R. 3011 and H.R. 1078) -- all provisions
Medicare Durable Medical Equipment Access Act of 2007
Client: APRIA HEALTHCARE INC · Firm: POWELL GOLDSTEIN LLP
Medicare Part B competitive bidding issues Medicare Part D Infusion therapy issues Medicare Home Infusion Therapy Coverage Act (H.R. 2567) - all provisions Medicare Durable Medical Equipment Access Act (H.R. 1845) - competitive bidding provisions
Medicare Home Infusion Therapy Coverage Act of 2007
Client: APRIA HEALTHCARE INC · Firm: POWELL GOLDSTEIN LLP
Medicare Part B competitive bidding issues Medicare Part D Infusion therapy issues Medicare Home Infusion Therapy Coverage Act (H.R. 2567) - all provisions Medicare Durable Medical Equipment Access Act (H.R. 1845) - competitive bidding provisions
Medicare Home Infusion Therapy Coverage Act of 2007
Client: NATIONAL HOME INFUSION ASSOCIATION · Firm: POWELL GOLDSTEIN LLP
Provisions relating to infusion therapy under Part D and Part B, general drug coverage and the Medicare Modernization Act and its aftermath Medicare Home Infusion Therapy Coverage Act (H.R. 2567) - all provisions Medicare reform issues pertaining to homecare and infusion therapy
To amend title XVIII of the Social Security Act to ensure adequate payment amounts for drugs and biologicals under part B of the Medicare Program.
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: POWELL GOLDSTEIN LLP
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments (H.R. 3011 and H.R. 1078) -- all provisions
Medicare, Medicaid, and SCHIP Extension Act of 2007
Client: THERAGENICS CORPORATION · Firm: POWELL GOLDSTEIN LLP
Issues regarding Medicare reimbursement and coverage Medicare, Medicaid, and SCHIP Extension Act of 2007 (S. 2499) -- relevant provisions
Stroke Treatment and Ongoing Prevention Act of 2005
Client: AMERICAN HEART ASSN · Firm: POWELL GOLDSTEIN LLP
Stroke Treatment and Ongoing Prevention Act (S. 1064/H.R. 989) Health information technology legislation (S. 1418, H.R. 4157) Women and heart disease related issues Health care quality issues
Stroke Treatment and Ongoing Prevention Act (S. 1064/H.R. 989) Health information technology legislation (S. 1418, H.R. 4157) Women and heart disease related issues Health care quality issues
Issues related to the quality of cancer care
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments [Comprehensive Cancer Care Improvement Act (H.R. 1078) -- all provisions; Legislation pertaining to Medicare average sales price for pharmaceuticals (H.R. 3011) -- all provisions]
Increase funding for National Institutes of Health programs as they pertain to cancer research
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THERAGENICS CORPORATION via POWELL GOLDSTEIN LLP
2008 · third_quarter · Q3
Issues regarding Medicare reimbursement and coverage for cancer therapies [Medicare Improvements for Patients and Providers Act (H.R. 6331) -- provision pertaining to brachytherapy]
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via POWELL GOLDSTEIN LLP
2008 · third_quarter · Q3
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments [Comprehensive Cancer Care Improvement Act (H.R. 1078) -- all provisions; Legislation pertaining to Medicare average sales price for pharmaceuticals (H.R. 3011) -- all provisions; Medicare Improvements for Patients and Providers Act (H.R. 6331) -- support provisions pertaining to physician payments]
Issues related to the quality of cancer care
Increase funding for National Institutes of Health programs as they pertain to cancer research
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THERAGENICS CORPORATION via POWELL GOLDSTEIN LLP
2008 · second_quarter · Q2
Issues regarding Medicare reimbursement and coverage for cancer therapies [Medicare Improvements for Patients and Providers Act (H.R. 6331) -- provision pertaining to brachytherapy]
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via POWELL GOLDSTEIN LLP
2008 · second_quarter · Q2
Increase funding for National Institutes of Health programs as they pertain to cancer research
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments [Comprehensive Cancer Care Improvement Act (H.R. 1078) -- all provisions; Legislation pertaining to Medicare average sales price for pharmaceuticals (H.R. 3011) -- all provisions; Medicare Improvements for Patients and Providers Act (H.R. 6331) -- support provisions pertaining to physician payments]
Issues related to the quality of cancer care
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THERAGENICS CORPORATION via POWELL GOLDSTEIN LLP
2008 · first_quarter · Q1
Issues regarding Medicare reimbursement and coverage for cancer therapies
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via POWELL GOLDSTEIN LLP
2008 · first_quarter · Q1
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments (Comprehensive Cancer Care Improvement Act (H.R. 1078) -- all provisions; Legislation pertaining to Medicare average sales price (H.R. 3011) -- all provisions)
Issues related to the quality of cancer care
Increase funding for National Institutes of Health programs as they pertain to cancer research
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THERAGENICS CORPORATION via POWELL GOLDSTEIN LLP
2007 · year_end · YY
Issues regarding Medicare reimbursement and coverage Medicare, Medicaid, and SCHIP Extension Act of 2007 (S. 2499) -- relevant provisions
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via POWELL GOLDSTEIN LLP
2007 · year_end · YY
Issues related to the quality of cancer care
Funding issues regarding the National Institutes of Health as they pertain to cancer research
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments (H.R. 3011 and H.R. 1078) -- all provisions
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via POWELL GOLDSTEIN LLP
2007 · year_end · RR
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments. Issues related to the quality of cancer care. Funding issues regarding the National Institutes of Health as they pertain to cancer research.
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments. Issues related to the quality of cancer care. Funding issues regarding the National Institutes of Health as they pertain to cancer research.
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments. Issues related to the quality of cancer care. Funding issues regarding the National Institutes of Health as they pertain to cancer research.
THERAGENICS CORPORATION via POWELL GOLDSTEIN LLP
2007 · mid_year · MM
Issues regarding Medicare reimbursement and coverage
Filing targets: Centers For Medicare and Medicaid Services (CMS), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL HOME INFUSION ASSOCIATION via POWELL GOLDSTEIN LLP
2007 · mid_year · MM
Provisions relating to infusion therapy under Part D and Part B, general drug coverage and the Medicare Modernization Act and its aftermath Medicare Home Infusion Therapy Coverage Act (H.R. 2567) - all provisions Medicare reform issues pertaining to homecare and infusion therapy
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ALLIANCE FOR INFUSION THERAPY via POWELL GOLDSTEIN LLP
2007 · mid_year · MM
Medicare competitive bidding Medicare reform regarding enteral nutrition
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
APRIA HEALTHCARE INC via POWELL GOLDSTEIN LLP
2007 · mid_year · MM
Medicare Part B competitive bidding issues Medicare Part D Infusion therapy issues Medicare Home Infusion Therapy Coverage Act (H.R. 2567) - all provisions Medicare Durable Medical Equipment Access Act (H.R. 1845) - competitive bidding provisions
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THERAGENICS CORPORATION via POWELL GOLDSTEIN LLP
2006 · year_end · YY
Issues regarding Medicare reimbursement and coverage Tax Relief and Health Care Act (H.R. 6111) - Medicare provisions
Filing targets: Centers For Medicare and Medicaid Services (CMS), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL HOME INFUSION ASSOCIATION via POWELL GOLDSTEIN LLP
2006 · year_end · YY
Provisions relating to infusion therapy under Part D and Part B, general drug coverage and the Medicare Modernization Act and its aftermath Medicare Home Infusion Therapy Consolidated Coverage Act (H.R. 5791) - all provisions
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ALLIANCE FOR INFUSION THERAPY via POWELL GOLDSTEIN LLP
2006 · year_end · YY
Medicare competitive bidding Medicare coding issues Medicare quality standards for enteral nutrition
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
APRIA HEALTHCARE INC via POWELL GOLDSTEIN LLP
2006 · year_end · YY
Part B respiratory therapy issues Part B Medicare competitive bidding issues Part D infusion therapy issues Part B payment for oxygen
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN HEART ASSN via POWELL GOLDSTEIN LLP
2006 · year_end · YY
Stroke Treatment and Ongoing Prevention Act (S. 1064/H.R. 989) Health information technology legislation (S. 1418, H.R. 4157) Women and heart disease related issues Health care quality issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL HOME INFUSION ASSOCIATION via POWELL GOLDSTEIN LLP
2006 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL HOME INFUSION ASSOCIATION via POWELL GOLDSTEIN LLP
2006 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THERAGENICS CORPORATION via POWELL GOLDSTEIN LLP
2006 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN HEART ASSN via POWELL GOLDSTEIN LLP
2006 · mid_year · MM
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL HOME INFUSION ASSOCIATION via POWELL GOLDSTEIN LLP
2005 · year_end · YY
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
APRIA HEALTHCARE INC via POWELL GOLDSTEIN LLP
2005 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HYOX MEDICAL TREATMENT CENTER INC via POWELL GOLDSTEIN LLP
2005 · year_end · YY
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
APRIA HEALTHCARE INC via POWELL GOLDSTEIN LLP
2005 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN HEART ASSN via POWELL GOLDSTEIN LLP
2005 · mid_year · MM
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ALLIANCE FOR INFUSION THERAPY via POWELL GOLDSTEIN LLP
2005 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THERAGENICS CORPORATION via POWELL GOLDSTEIN LLP
2005 · mid_year · MM
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL HOME INFUSION ASSOCIATION via POWELL GOLDSTEIN LLP
2005 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HYOX MEDICAL TREATMENT CENTER INC via POWELL GOLDSTEIN LLP
2005 · mid_year · MM
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HYOX MEDICAL TREATMENT CENTER INC via POWELL GOLDSTEIN LLP
2005 · mid_year · RR
THERAGENICS CORPORATION via POWELL GOLDSTEIN LLP
2004 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN HEART ASSN via POWELL GOLDSTEIN LLP
2004 · year_end · YY
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL HOME INFUSION ASSOCIATION via POWELL GOLDSTEIN LLP
2004 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN HEART ASSN via POWELL GOLDSTEIN LLP
2004 · mid_year · MM
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ALLIANCE FOR INFUSION THERAPY via POWELL GOLDSTEIN LLP
2004 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
APRIA HEALTHCARE INC via POWELL GOLDSTEIN LLP
2003 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NAMM INTL MUSIC PRODUCTS ASSN via POWELL GOLDSTEIN LLP
2003 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL HOME INFUSION ASSOCIATION via POWELL GOLDSTEIN LLP
2003 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
APRIA HEALTHCARE INC via POWELL GOLDSTEIN LLP
2003 · mid_year · MT
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NETRX via POWELL GOLDSTEIN LLP
2003 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN HEART ASSN via POWELL GOLDSTEIN LLP
2003 · year_end · YY
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ASSN OF COMMUNITY CANCER via POWELL GOLDSTEIN LLP
2002 · year_end · YT
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN HEART ASSN via POWELL GOLDSTEIN LLP
2002 · year_end · YY
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
APRIA HEALTHCARE INC via POWELL GOLDSTEIN LLP
2002 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ALLIANCE FOR INFUSION THERAPY via POWELL GOLDSTEIN LLP
2002 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSN OF COMMUNITY CANCER via POWELL GOLDSTEIN LLP
2002 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL HOME INFUSION ASSOCIATION via POWELL GOLDSTEIN LLP
2002 · year_end · RR
APRIA HEALTHCARE INC via POWELL GOLDSTEIN LLP
2002 · mid_year · RR
AMERICAN HEART ASSN via POWELL GOLDSTEIN LLP
2001 · year_end · YY
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
CONSOLIDATED BILLING COALITION via POWELL GOLDSTEIN LLP
2000 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSN OF COMMUNITY CANCER via POWELL GOLDSTEIN LLP
2000 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RESPIRONICS via POWELL GOLDSTEIN LLP
2000 · year_end · YY
Filing targets: Centers For Medicare and Medicaid Services (CMS)
CONSOLIDATED BILLING COALITION via POWELL GOLDSTEIN LLP
2000 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CITY OF DEKALB via POWELL GOLDSTEIN LLP
2000 · mid_year · MM
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Federal Aviation Administration (FAA), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR)
CITY OF FREEPORT via POWELL GOLDSTEIN LLP
2000 · mid_year · MM
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Federal Aviation Administration (FAA), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR)
INTL ANTICOUNTERFEITING COALITION (IACC) via POWELL GOLDSTEIN LLP
2000 · mid_year · MM
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Federal Aviation Administration (FAA), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE, State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR)
CONSOLIDATED BILLING COALITION via POWELL GOLDSTEIN LLP
2000 · year_end · RR
ASSN OF COMMUNITY CANCER via POWELL GOLDSTEIN LLP
2000 · year_end · RR
NATIONAL ALLIANCE FOR INFUSION THERAPY via POWELL GOLDSTEIN LLP
1999 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
U S ONCOLOGY via POWELL GOLDSTEIN LLP
1999 · year_end · YY
Filing targets: Centers For Medicare and Medicaid Services (CMS), SENATE
RESPIRONICS via POWELL GOLDSTEIN LLP
1999 · year_end · YY
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
U S ONCOLOGY via POWELL GOLDSTEIN LLP
1999 · mid_year · MM
Filing targets: Centers For Medicare and Medicaid Services (CMS), SENATE
NATIONAL ALLIANCE FOR INFUSION THERAPY via POWELL GOLDSTEIN LLP
1999 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RESPIRONICS via POWELL GOLDSTEIN LLP
1999 · mid_year · RR